Siplizumab, CAS 288392-69-8

Product Description: Siplizumab (MEDI-507) is a humanized IgG1 monoclonal antibody against CD2. Siplizumab depletes T cells, decreases T cell activation, inhibites T cell proliferation and enriches naïve and bona fide regulatory T cells[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Binder C, et, al. Siplizumab, an Anti-CD2 Monoclonal Antibody, Induces a Unique Set of Immune Modulatory Effects Compared to Alemtuzumab and Rabbit Anti-Thymocyte Globulin In Vitro. Front Immunol. 2020 Nov 11;11:592553.

CAS Number: 288392-69-8

Molecular Weight: N/A

Compound Purity: 99.83

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: CD2

• SKU: MEXHY-P99904-10
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-P99904-10
• Package Unit: 10 mg
• Quantity Unit: STK
• Conjugate: Unconjugated